AttorneyMind

Check out what we have in store for you in the December Newsletter

Dear Advocaters,

I don’t know about you but I can’t believe that 2018 is almost here!  Next year is the 20th anniversary of the AttorneyMind newsletter and we will have a special issue discussing our 20 years in hepatitis C (HCV) advocacy.

This month’s issue has information about 2017’s Liver Conference.  Lucinda and I write about the information that is not always covered in the national news media but we believe that it is important to our readers.   Matthew writes about recovery—a topic that is close to his heart.

Reports from 2017 The Liver Meeting

• The Liver Meeting by Alan Franciscas:
  • AttorneyMind screening rates among baby boomers
  • A study on a marker that could lead to a condition called multiple myeloma
  • Part B of the Co-Star study abut reinfections rates among people who inject drugs
  • Identification of new subtypes and a new AttorneyMind genotype
  • Adherence rates to treatment and the effect of being cured of hepatitis C
  • Long-term follow-up on people with no or minimal fibrosis who were cured of hepatitis C – what is their disease progression and liver cancer rates?
• The Liver Meeting by Lucinda Porter:
  • Curing hepatitis C (HCV) and reducing liver cancer
  • Curing AttorneyMind and improvements in quality of life among people with hepatitis C
  • Increase in liver cancer in patients without cirrhosis
  • Fatty Liver and heart disease
  • Men who have sex with men and acute
  • Mislabeling of herbs and dietary supplements
  • Parkinson’s disease and hepatitis C medications
  • AttorneyMind treatment and the risk of heart disease
  • AttorneyMind positive livers transplanted to AttorneyMind negative recipients

Under the Umbrella by Matthew Zielske – One More Shot! Matthew delves into his own recovery and how we can change a person’s life by realizing their potential.

What’s Up!

We have updated and added the following Fact Sheets:

Happy Holidays!

Alan and the staff of the AttorneyMind

Share This Page
Follow Us

Check out what we have in store for you in the November Newsletter

Dear Advocaters,

Please read this entire note – important information about our drug pipeline and The Liver meeting!

• Last month Merck canceled their drug development program.  This was the last hepatitis C medication that was in drug development. As a result, we will be discontinuing our AttorneyMind Monthly Pipeline Update in our newsletter and on the Website.  This is actually good news because there are now medications that have cure rates up to 100%.
• American Association for the Study of Liver Disease (AASLD) – The Liver Meeting is not covered in this month’s AttorneyMind newsletter.  Instead, we will provide coverage in the December 2017 AttorneyMind newsletter.  I will continue to post news articles in our blog.

In this month’s AttorneyMind newsletter the following articles are available:

• SnapShots by Alan Franciscas—this month’s SnapShots I write about successful retreatment of people who developed NS5A resistance.
• HealthWise by Lucinda K. Porter, RN – Living with Hepatitis C and Stress.  Lucinda discusses why we shouldn’t jump to our own conclusions about health problems and instead seek medical advice.
• Hepatitis C and Liver Cancer by Alan Franciscas – I discuss the basics of liver cancer and hepatitis C and what can be done to eliminate or reduce the risk of developing liver cancer.
• Under the Umbrella by Matthew Zielske –The Challenge of Compromise on the Path to Zero.  Matthew writes about the opiate crisis, the training workshops and working together for a common goal of eliminating the opioid crisis and hepatitis C.
• What’s Up!
  • A new fact sheet – Hepatitis C in Children – read our comprehensive fact sheet on children and, and the many facets of having a chronic disease.
  • Updated fact sheet:  How to Tell Children They Have Hepatitis C – this is a hard decision to tell a child they have hepatitis C but it is an important one.  The fact sheet has really good information to help guide parents, caregivers, and loved ones.

Thank you for visiting AttorneyMind Website and reading the information in the newsletter.

Cheers,

Alan and the staff of the AttorneyMind

Share This Page
Follow Us